Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Acute myeloid leukemia with t(19;21)(q13;q22) and marked eosinophilia.

Kubota Y, Kamachi K, Wakayama K, Kitamura H, Yoshihara M, Hisatomi T, Fukushima N, Ichinohe T, Sueoka E, Kimura S.

Ann Hematol. 2018 Jun 27. doi: 10.1007/s00277-018-3408-4. [Epub ahead of print] No abstract available.

PMID:
29951913
2.

Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments.

Nakashima C, Sato A, Abe T, Kato J, Hirai M, Nakamura T, Komiya K, Sueoka E, Kimura S, Sueoka-Aragane N.

Oncotarget. 2018 May 18;9(38):25181-25192. doi: 10.18632/oncotarget.25388. eCollection 2018 May 18.

3.

Synchronous mantle cell lymphoma and lung adenocarcinoma presenting in a pleural effusion: A rare tumour combination and a potential pitfall of cytodiagnosis.

Kai K, Ryu Y, Kamochi K, Nishioka A, Kubota Y, Nakamura M, Kimura S, Sueoka E, Aishima S.

Cytopathology. 2018 Mar 25. doi: 10.1111/cyt.12532. [Epub ahead of print] No abstract available.

PMID:
29575128
4.

Differentiated embryo chondrocyte plays a crucial role in DNA damage response via transcriptional regulation under hypoxic conditions.

Nakamura H, Bono H, Hiyama K, Kawamoto T, Kato Y, Nakanishi T, Nishiyama M, Hiyama E, Hirohashi N, Sueoka E, Poellinger L, Tanimoto K.

PLoS One. 2018 Feb 21;13(2):e0192136. doi: 10.1371/journal.pone.0192136. eCollection 2018.

5.

Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells.

Fujiki H, Watanabe T, Sueoka E, Rawangkan A, Suganuma M.

Mol Cells. 2018 Feb 28;41(2):73-82. doi: 10.14348/molcells.2018.2227. Epub 2018 Jan 31. Review.

6.

Deep sequencing of the T cell receptor visualizes reconstitution of T cell immunity in mogamulizumab-treated adult T cell leukemia.

Shindo T, Kitaura K, Ureshino H, Kamachi K, Miyahara M, Doi K, Watanabe T, Sueoka E, Shin-I T, Suzuki R, Kimura S.

Oncoimmunology. 2017 Dec 11;7(3):e1405204. doi: 10.1080/2162402X.2017.1405204. eCollection 2018.

PMID:
29399406
7.

Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate.

Fujiki H, Sueoka E, Rawangkan A, Suganuma M.

J Cancer Res Clin Oncol. 2017 Dec;143(12):2401-2412. doi: 10.1007/s00432-017-2515-2. Epub 2017 Sep 23. Review.

8.

Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.

Kobayashi-Watanabe N, Sato A, Watanabe T, Abe T, Nakashima C, Sueoka E, Kimura S, Sueoka-Aragane N.

Lung Cancer. 2017 Aug;110:35-41. doi: 10.1016/j.lungcan.2017.05.017. Epub 2017 May 25.

PMID:
28676216
9.

Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge.

Nakamura T, Watanabe N, Sato A, Komiya K, Umeguchi H, Hosomi T, Hirai M, Sueoka E, Kimura S, Sueoka-Aragane N.

Oncol Lett. 2017 Jun;13(6):4939-4946. doi: 10.3892/ol.2017.6085. Epub 2017 Apr 24.

10.

Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma.

Katsuya H, Shimokawa M, Ishitsuka K, Kawai K, Amano M, Utsunomiya A, Hino R, Hanada S, Jo T, Tsukasaki K, Moriuchi Y, Sueoka E, Yoshida S, Suzushima H, Miyahara M, Yamashita K, Eto T, Suzumiya J, Tamura K.

Blood. 2017 Jul 6;130(1):39-47. doi: 10.1182/blood-2017-01-757542. Epub 2017 May 17.

11.

Erratum to "Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer" [Lung Cancer 69/2 (2010) 232-238].

Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, Sueoka E.

Lung Cancer. 2016 Nov;101:148. doi: 10.1016/j.lungcan.2016.05.005. Epub 2016 May 27. No abstract available.

PMID:
27241680
12.

Mutation Profile of B-Raf Gene Analyzed by fully Automated System and Clinical Features in Japanese Melanoma Patients.

Ide M, Koba S, Sueoka-Aragane N, Sato A, Nagano Y, Inoue T, Misago N, Narisawa Y, Kimura S, Sueoka E.

Pathol Oncol Res. 2017 Jan;23(1):181-188. doi: 10.1007/s12253-016-0121-2. Epub 2016 Oct 21.

PMID:
27766572
13.

Reversible Liver Steatosis Induced by Chemotherapy of Mixed-phenotype Acute Leukemia.

Nishioka A, Kubota Y, Sueoka E, Kimura S.

Intern Med. 2016;55(8):1025-6. doi: 10.2169/internalmedicine.55.5685. Epub 2016 Apr 15. No abstract available.

14.

[Results of Training for Personnel Involved in Blood-Transfusion Testing Outside of Regular Work Hours at Saga University Hospital].

Yamada M, Yamada N, Higashitani T, Ohta S, Sueoka E.

Rinsho Byori. 2015 Nov;63(11):1259-63. Japanese.

PMID:
26995870
15.

Acute myeloid leukemia with t(3;8)(q26;q24) complicated by diabetes insipidus.

Kubota Y, Ichinohe T, Yoshimura M, Itamura H, Hisatomi T, Fukushima N, Sueoka E, Kimura S.

Ann Hematol. 2016 Mar;95(4):653-5. doi: 10.1007/s00277-016-2595-0. Epub 2016 Jan 11. No abstract available.

PMID:
26754632
16.

Torin2 Potentiates Anticancer Effects on Adult T-Cell Leukemia/Lymphoma by Inhibiting Mammalian Target of Rapamycin.

Watanabe T, Sato A, Kobayashi-Watanabe N, Sueoka-Aragane N, Kimura S, Sueoka E.

Anticancer Res. 2016 Jan;36(1):95-102.

PMID:
26722032
17.

2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent.

Yokoo M, Kubota Y, Motoyama K, Higashi T, Taniyoshi M, Tokumaru H, Nishiyama R, Tabe Y, Mochinaga S, Sato A, Sueoka-Aragane N, Sueoka E, Arima H, Irie T, Kimura S.

PLoS One. 2015 Nov 4;10(11):e0141946. doi: 10.1371/journal.pone.0141946. eCollection 2015.

18.

Treatment and survival among 1594 patients with ATL.

Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, Saburi Y, Miyahara M, Sueoka E, Uike N, Yoshida S, Yamashita K, Tsukasaki K, Suzushima H, Ohno Y, Matsuoka H, Jo T, Amano M, Hino R, Shimokawa M, Kawai K, Suzumiya J, Tamura K; ATL-Prognostic Index Project.

Blood. 2015 Dec 10;126(24):2570-7. doi: 10.1182/blood-2015-03-632489. Epub 2015 Sep 11.

19.

Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compounds.

Fujiki H, Sueoka E, Watanabe T, Suganuma M.

J Cancer Prev. 2015 Mar;20(1):1-4. doi: 10.15430/JCP.2015.20.1.1. Review.

20.

Highlights of the Twelfth Japan-Korea Joint Symposium on Cancer and Ageing Research.

Suganuma M, Park TJ, Sueoka E, Iida K, Tanaka Y.

J Cancer Res Clin Oncol. 2015 Nov;141(11):1953-61. doi: 10.1007/s00432-015-1959-5. Epub 2015 Mar 29.

PMID:
25820597
21.

Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.

Fujiki H, Sueoka E, Watanabe T, Suganuma M.

J Cancer Res Clin Oncol. 2015 Sep;141(9):1511-22. doi: 10.1007/s00432-014-1899-5. Epub 2014 Dec 28. Review.

PMID:
25544670
22.

Correlation between plasma DNA and tumor status in an animal model.

Sueoka-Aragane N, Sato A, Kobayashi N, Ide M, Yokoo M, Nagano Y, Sueoka E, Okada S, Kimura S.

PLoS One. 2014 Dec 2;9(12):e111881. doi: 10.1371/journal.pone.0111881. eCollection 2014.

23.

Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer.

Umeguchi H, Sueoka-Aragane N, Kobayashi N, Nakamura T, Sato A, Takeda Y, Hayashi S, Sueoka E, Kimura S.

Oncol Rep. 2015 Jan;33(1):391-6. doi: 10.3892/or.2014.3560. Epub 2014 Oct 22.

PMID:
25338771
24.

ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia.

Yoshimura M, Kojima K, Tomimasu R, Fukushima N, Hayashi S, Sueoka E, Kimura S.

Int J Hematol. 2014 Dec;100(6):611-4. doi: 10.1007/s12185-014-1666-z. Epub 2014 Sep 12.

PMID:
25212679
25.

Therapeutic management in cardiac lymphoma.

Yoshihara M, Itamura H, Fukushima N, Itoh M, Furukawa K, Nagatomo D, Kamachi K, Kitamura H, Shindo T, Kubota Y, Sueoka E, Morita S, Ichinohe T, Kimura S.

Leuk Lymphoma. 2014 May;55(5):1215-7. doi: 10.3109/10428194.2013.828355. Epub 2013 Sep 3. No abstract available.

PMID:
23885797
26.

[Direct identification method for bacteria in positive blood culture bottles using MALDI biotyper].

Uki N, Oho M, Nagasawa Z, Higashitani T, Ohta S, Sueoka E, Miyamoto H.

Rinsho Byori. 2013 Mar;61(3):224-30. Japanese.

PMID:
23785791
27.

Tumor promoters: from chemicals to inflammatory proteins.

Fujiki H, Sueoka E, Suganuma M.

J Cancer Res Clin Oncol. 2013 Oct;139(10):1603-14. doi: 10.1007/s00432-013-1455-8. Epub 2013 Jun 12. Review.

PMID:
23756937
28.

Development of lymphoproliferative diseases by hypoxia inducible factor-1alpha is associated with prolonged lymphocyte survival.

Sueoka E, Sueoka-Aragane N, Sato A, Ide M, Nakamura H, Sotomaru Y, Taya C, Yonekawa H, Kitagawa T, Kubota Y, Kimura S, Nakachi K, Tanimoto K.

PLoS One. 2013 Apr 12;8(4):e57833. doi: 10.1371/journal.pone.0057833. Print 2013.

29.

Platelets with a W127X mutation in GPIX express sufficient residual amounts of GPIbα to support adhesion to von Willebrand factor and collagen.

Takata Y, Kanaji T, Moroi M, Seki R, Sano M, Nakazato S, Sueoka E, Imamura Y, Okamura T.

Int J Hematol. 2012 Dec;96(6):733-42. doi: 10.1007/s12185-012-1216-5. Epub 2012 Nov 11.

PMID:
23143686
30.

Application of a highly sensitive detection system for epidermal growth factor receptor mutations in plasma DNA.

Nakamura T, Sueoka-Aragane N, Iwanaga K, Sato A, Komiya K, Kobayashi N, Hayashi S, Hosomi T, Hirai M, Sueoka E, Kimura S.

J Thorac Oncol. 2012 Sep;7(9):1369-81. doi: 10.1097/JTO.0b013e31825f2821.

31.

Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma.

Katsuya H, Yamanaka T, Ishitsuka K, Utsunomiya A, Sasaki H, Hanada S, Eto T, Moriuchi Y, Saburi Y, Miyahara M, Sueoka E, Uike N, Yoshida S, Yamashita K, Tsukasaki K, Suzushima H, Ohno Y, Matsuoka H, Jo T, Suzumiya J, Tamura K.

J Clin Oncol. 2012 May 10;30(14):1635-40. doi: 10.1200/JCO.2011.38.2101. Epub 2012 Apr 2.

PMID:
22473153
32.

Successful reduced-intensity umbilical cord blood transplant for fulminant hemophagocytic syndrome in an adult with pre-existing rheumatoid arthritis and autoimmune hemolytic anemia.

Itamura H, Fukushima N, Kondo S, Urata C, Tanaka-Yoshimura M, Yokoo M, Ide M, Hisatomi T, Kubota Y, Sueoka E, Ichinohe T, Kimura S.

Leuk Lymphoma. 2012 Nov;53(11):2307-9. doi: 10.3109/10428194.2012.680453. Epub 2012 Apr 19. No abstract available.

PMID:
22452588
33.

[Influences of %T>MIC achievement probability due to the difference of the MIC measurement concentration range-analysis of meropenem for Pseudomonas aeruginosa-].

Nagasawa Z, Nakashima Y, Fukutomi Y, Uki N, Kusaba K, Nagumo F, Ohta S, Sueoka E, Miyamoto H.

Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi. 2011;22(1-2):11-22. Japanese.

PMID:
22352705
34.

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R.

J Clin Oncol. 2011 Nov 20;29(33):4410-6. doi: 10.1200/JCO.2011.35.6287. Epub 2011 Oct 11.

PMID:
21990393
35.

A noninvasive system for monitoring resistance to epidermal growth factor receptor tyrosine kinase inhibitors with plasma DNA.

Nakamura T, Sueoka-Aragane N, Iwanaga K, Sato A, Komiya K, Abe T, Ureshino N, Hayashi S, Hosomi T, Hirai M, Sueoka E, Kimura S.

J Thorac Oncol. 2011 Oct;6(10):1639-48. doi: 10.1097/JTO.0b013e31822956e8.

36.

Lenalidomide in combination with dexamethasone induced rhabdomyolysis in a multiple myeloma patient treated with pravastatin.

Urata C, Yoshimura M, Itamura H, Hisatomi T, Kubota Y, Fukushima N, Sueoka E, Kimura S.

Int J Hematol. 2011 Aug;94(2):216-217. doi: 10.1007/s12185-011-0903-y. Epub 2011 Aug 3. No abstract available.

PMID:
21811773
37.

Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients.

Tanaka A, Sueoka-Aragane N, Nakamura T, Takeda Y, Mitsuoka M, Yamasaki F, Hayashi S, Sueoka E, Kimura S.

Lung Cancer. 2012 Jan;75(1):89-94. doi: 10.1016/j.lungcan.2011.06.004. Epub 2011 Jul 5.

PMID:
21733594
38.

A fully integrated, automated and rapid detection system for KRAS mutations.

Ureshino N, Sueoka-Aragane N, Nakamura T, Sato A, Komiya K, Iwanaga K, Mitsuoka M, Takeda Y, Hayashi S, Sueoka E, Kimura S.

Oncol Rep. 2011 Sep;26(3):609-13. doi: 10.3892/or.2011.1341. Epub 2011 Jun 7.

PMID:
21667033
39.

A fully integrated and automated detection system for single nucleotide polymorphisms of UGT1A1 and CYP2C19.

Ureshino N, Aragane N, Nakamura T, Ide M, Mochinaga S, Fukushima N, Hayashi S, Sueoka E, Kimura S.

Oncol Res. 2011;19(3-4):111-4.

PMID:
21473286
40.

NK314 potentiates antitumor activity with adult T-cell leukemia-lymphoma cells by inhibition of dual targets on topoisomerase II{alpha} and DNA-dependent protein kinase.

Hisatomi T, Sueoka-Aragane N, Sato A, Tomimasu R, Ide M, Kurimasa A, Okamoto K, Kimura S, Sueoka E.

Blood. 2011 Mar 31;117(13):3575-84. doi: 10.1182/blood-2010-02-270439. Epub 2011 Jan 18.

41.

Gangrenous cheilitis associated with all-trans retinoic acid therapy for acute promyelocytic leukemia.

Tanaka M, Fukushima N, Itamura H, Urata C, Yokoo M, Ide M, Hisatomi T, Tomimasu R, Sueoka E, Kimura S.

Int J Hematol. 2010 Jan;91(1):132-5. doi: 10.1007/s12185-009-0468-1. Epub 2009 Dec 25.

PMID:
20035486
42.

Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer.

Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, Sueoka E.

Lung Cancer. 2010 Aug;69(2):232-8. doi: 10.1016/j.lungcan.2009.10.010. Epub 2009 Nov 14. Erratum in: Lung Cancer. 2016 Nov;101:148.

PMID:
19914733
43.

Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells.

Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, Sueoka E.

J Cancer Res Clin Oncol. 2010 Mar;136(3):465-73. doi: 10.1007/s00432-009-0679-0. Epub 2009 Sep 16.

PMID:
19756735
44.

Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier.

Fukushima N, Mizuta T, Tanaka M, Yokoo M, Ide M, Hisatomi T, Kuwahara N, Tomimasu R, Tsuneyoshi N, Funai N, Sueoka E.

Ann Oncol. 2009 Dec;20(12):2013-7. doi: 10.1093/annonc/mdp230. Epub 2009 Jun 26.

PMID:
19561036
45.

Establishment of a new method, transcription-reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer.

Sato A, Sueoka-Aragane N, Saitoh J, Komiya K, Hisatomi T, Tomimasu R, Hayashi S, Sueoka E.

J Cancer Res Clin Oncol. 2008 Nov;134(11):1191-7. doi: 10.1007/s00432-008-0402-6. Epub 2008 May 7.

PMID:
18461365
46.

Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Yukitake M, Sueoka E, Sueoka-Aragane N, Sato A, Ohashi H, Yakushiji Y, Saito M, Osame M, Izumo S, Kuroda Y.

J Neurovirol. 2008 Apr;14(2):130-5. doi: 10.1080/13550280701883840.

PMID:
18444084
47.

Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1.

Sueoka-Aragane N, Imai K, Komiya K, Sato A, Tomimasu R, Hisatomi T, Sakuragi T, Mitsuoka M, Hayashi S, Nakachi K, Sueoka E.

Cancer Sci. 2008 Jun;99(6):1180-7. doi: 10.1111/j.1349-7006.2008.00804.x. Epub 2008 Apr 14.

48.

Non-germinal cell phenotype and bcl-2 expression in primary adrenal diffuse large B-cell lymphoma.

Ide M, Fukushima N, Hisatomi T, Tsuneyoshi N, Tanaka M, Yokoo M, Tomimasu R, Funai N, Sueoka E.

Leuk Lymphoma. 2007 Nov;48(11):2244-6. No abstract available.

PMID:
17926189
49.

Expression of Myc target gene mina53 in subtypes of human lymphoma.

Teye K, Arima N, Nakamura Y, Sakamoto K, Sueoka E, Kimura H, Tsuneoka M.

Oncol Rep. 2007 Oct;18(4):841-8.

PMID:
17786344
50.

Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group Study 9004.

Tobinai K, Takeyama K, Arima F, Aikawa K, Kobayashi T, Hanada S, Kasai M, Ogura M, Sueoka E, Mukai K, Tajima K, Fukuda H, Shirakawa S, Hotta T, Masanori S; Lymphoma Study Group of the Japan Clinical Oncology Group.

Cancer Sci. 2007 Sep;98(9):1350-7. Epub 2007 Jul 19.

Supplemental Content

Loading ...
Support Center